文献速递慢性肾脏病肾小球疾病遗传性与小管间质肾病

空间分布不同的TREM2阳性巨噬细胞在糖尿病肾病中发挥区室特异性保护作用

Spatially Distinct Triggering Receptor Expressed on Myeloid Cells 2 + Macrophages Are Associated with Compartment-Specific Protection in Diabetic Kidney Disease.
PubMed 文献 · J Am Soc Nephrol · 2026-09-14

该研究整合单细胞RNA测序、空间转录组分析和骨髓移植实验,探讨TREM2阳性巨噬细胞在糖尿病肾病中的分布与功能。发现TREM2诱导发生于两种空间不同的巨噬细胞群:定位于肾小球周围微环境的Mrc1阳性肾脏驻留巨噬细胞和浸润肾小管间质的Ccr2阳性单核细胞来源巨噬细胞。骨髓嵌合体实验表明,驻留TREM2保护肾小球,而供体来源TREM2限制肾小管间质损伤。

要点

  • TREM2缺陷加重糖尿病小鼠白蛋白尿、降低GFR并加重肾小球和肾小管损伤
  • TREM2在肾小球周围驻留巨噬细胞和肾小管间质单核细胞来源巨噬细胞中诱导
  • 驻留TREM2保护肾小球结构,供体来源TREM2限制肾小管间质损伤

核心结论

  • 表达TREM2的巨噬细胞在糖尿病肾病中贡献区室特异性保护反应。
  • TREM2缺陷与更严重的糖尿病肾小球和肾小管损伤相关,供体造血和受体区室呈现不同表型。

研究设计与样本

  • 整合单细胞RNA测序、糖尿病OVE26肾脏空间转录组分析及高脂饮食加链脲佐菌素诱导糖尿病模型中的双向骨髓移植实验。

主要发现

  • 全局TREM2缺陷显著加重糖尿病肾病肾小管间质损伤和肾小球肥大,确立TREM2为保护因子。
  • 糖尿病肾脏中TREM2诱导发生于两种空间不同的巨噬细胞群:Mrc1阳性肾脏驻留巨噬细胞定位于肾小球周围微环境,Ccr2阳性单核细胞来源巨噬细胞浸润肾小管间质。
  • 转录组和功能分析符合TREM2在巨噬细胞吞噬和脂质处理程序中的作用;其缺失导致吞噬体和内吞途径下调,凋亡碎片和脂质聚集物清除失败,在肾小管间质尤为明显。
  • 双向骨髓移植实验提示受体驻留TREM2更与肾小球结构保护相关,而供体来源造血TREM2更与限制肾小管脂质积累、凋亡肾小管上皮细胞和肾小管间质损伤相关。

临床怎么用

  • TREM2可作为糖尿病肾病区室特异性保护靶点,肾小球与肾小管间质保护可能需分别靶向驻留与单核细胞来源巨噬细胞。

局限性

  • 研究基于糖尿病小鼠模型,结论向人类糖尿病肾病的转化需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Triggering receptor expressed on myeloid cells 2 deficiency worsened albuminuria, lowered GFR, and aggravated glomerular and tubular injury in diabetic mice. Triggering receptor expressed on myeloid cells 2 was induced in resident-associated macrophages in the glomerular niche and monocyte-derived macrophages in the tubulointerstitium. Bone marrow chimeras showed that resident triggering receptor expressed on myeloid cells 2 protected the glomerulus, whereas donor-derived triggering receptor expressed on myeloid cells 2 limited tubulointerstitial injury. BACKGROUND: Diabetic kidney disease (DKD) is driven by complex pathologic mechanisms including lipid accumulation, chronic inflammation, and fibrosis, contributing to progressive kidney dysfunction. Macrophages are key contributors to DKD pathogenesis, yet their functional heterogeneity in the diabetic kidney remains poorly defined. Although triggering receptor expressed on myeloid cells 2 (TREM2 + ) macrophages have been identified within the diabetic microenvironment, the relationship between their developmental origin, anatomic localization, and functional specialization remains unclear. METHODS: In this study, we integrated single-cell RNA sequencing, spatial transcriptomic analysis of diabetic OVE26 kidneys, and reciprocal bone marrow transplantation in a high-fat diet plus streptozotocin-induced diabetic model to examine how TREM2 + macrophages are distributed across renal compartments and how TREM2 deficiency affects DKD injury. RESULTS: Global TREM2 deficiency markedly exacerbated tubulointerstitial injury and glomerular hypertrophy in DKD, establishing TREM2 as a protective factor. Single-cell RNA sequencing and spatial mapping revealed that TREM2 induction in diabetic kidneys occurs in 2 spatially distinct macrophage populations: Mrc1 + kidney-resident macrophages localized to the periglomerular niche and Ccr2 + monocyte-derived macrophages infiltrating the tubulointerstitium. Transcriptomic and functional analyses were consistent with a role of TREM2 in macrophage phagocytic and lipid-handling programs. Its loss led to the downregulation of phagosome and endocytic pathways, resulting in failed clearance of apoptotic debris and lipid aggregates, which was particularly pronounced in the tubulointerstitium. Reciprocal bone marrow transplant experiments suggest that recipient-resident TREM2 was more associated with preservation of glomerular structure, whereas donor-derived hematopoietic TREM2 was more strongly associated with limiting tubular lipid accumulation, apoptotic tubular epithelial cells, and tubulointerstitial injury. CONCLUSIONS: These findings suggested that TREM2-expressing macrophages contributed to compartment-specific protective responses in DKD. TREM2 deficiency was associated with greater diabetic glomerular and tubular injury, with distinct phenotypes observed in donor hematopoietic and recipient compartments.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Fu J, Niu Y, Chang D, et al. Spatially Distinct Triggering Receptor Expressed on Myeloid Cells 2 + Macrophages Are Associated with Compartment-Specific Protection in Diabetic Kidney Disease. J Am Soc Nephrol. 2026. PMID: 42735028. doi:10.1681/ASN.0000001248

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。